IGC240517C7500
- 0.05
- 0.000.00%
IGC Pharma Newsroom
IGC Pharma to Attend BIO International Convention 2024
IGC Pharma, Inc (NYSE:IGC) ("IGC" or the "Company"), today announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6,
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
6.7 Million Americans Live With Alzheimer's - IGC Pharma Believes They Deserve Treatment Options...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent And Established Law And Regulations (Two Confidential...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent An
Express News | 'Declassifying Cannabis Still Leaves Pot Stocks In Limbo' - Wall Street Journal
Express News | Shares of Cannabis-related Stocks Are Trading Higher Following Reports Suggesting the DEA Plans to Reclassify Cannabis as a Less Dangerous Drug
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. NanoVibronix (NASDAQ:NAOV) shares moved upwar
Express News | Shares of Cannabis Stocks Are Trading Higher Following a Report Indicating the DEA Is Moving to Reclassify Marijuana as a Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
Express News | Watching Shares Of Marijuana Stocks; Traders Circulate Comments From The TDR Podcast Saying "We've Heard Rumors That Potentially That Announcement Could Be Coming This Week - Whatever The Decision May Be", "I'm Hearing From Some Sources That Pro-Marijuana
Express News | IGC Pharma Announces Interim Results For IGC-AD1 In Reducing Alzheimer's Agitation; Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared To Placebo
Express News | IGC Pharma Inc- Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared to Placebo
Express News | IGC Pharma Inc- Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
Express News | IGC Pharma Inc Files for Resale of up to 8.8 Mln Shares by the Selling Stockholder - SEC Filing
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersClene (NASDAQ:CLNN) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. Talphera (NASDAQ:TLPH) shares moved upwards b
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associated with Alzheimer's.The data demonstrates a clinically significant
Express News | IGC Pharma Shares Are Trading Higher After Interim Phase 2 Data Showed a Reduction in Alzheimer's Agitation at Week Two
Express News | IGC Pharma Announces Interim Phase 2 Data Showing IGC-AD1 Achieved Secondary Endpoint And Demonstrated A Clinical Reduction In Alzheimer's Agitation At Week Two
Express News | IGC Pharma: Demonstrates Clinical Reduction, Approaching Statistical Significance, at Week Two, in Agitation in Dementia Due to Alzheimer's in Study
Express News | IGC Pharma Inc: Study Achieves Secondary End Point